Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.91 USD | +0.82% | -1.60% | -45.38% |
Mar. 20 | ILJIN SNT Delivers a Letter to Aurinia Pharmaceuticals | CI |
Mar. 07 | Aurinia Pharmaceuticals Insider Sold Shares Worth $711,094, According to a Recent SEC Filing | MT |
Financials (USD)
Sales 2024 * | 223M | Sales 2025 * | 288M | Capitalization | 704M |
---|---|---|---|---|---|
Net income 2024 * | -6M | Net income 2025 * | 58M | EV / Sales 2024 * | 1.61 x |
Net cash position 2024 * | 344M | Net cash position 2025 * | 390M | EV / Sales 2025 * | 1.09 x |
P/E ratio 2024 * |
-88.5
x | P/E ratio 2025 * |
12.3
x | Employees | 300 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 92.55% |
Latest transcript on Aurinia Pharmaceuticals Inc.
1 day | +0.82% | ||
1 week | -2.77% | ||
Current month | -2.00% | ||
1 month | -1.80% | ||
3 months | -38.85% | ||
6 months | -31.71% | ||
Current year | -45.38% |
Managers | Title | Age | Since |
---|---|---|---|
Michael Martin
FOU | Founder | 52 | 93-06-15 |
Peter Greenleaf
CEO | Chief Executive Officer | 54 | 19-04-28 |
Robert Foster
FOU | Founder | 65 | 93-06-15 |
Members of the board | Title | Age | Since |
---|---|---|---|
Robert Foster
FOU | Founder | 65 | 93-06-15 |
R. MacKay-Dunn
BRD | Director/Board Member | 73 | 19-06-25 |
Peter Greenleaf
CEO | Chief Executive Officer | 54 | 19-04-28 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.10% | 0 M€ | 0.00% | - | |
0.05% | 0 M€ | 0.00% | - | |
0.01% | 9 M€ | -.--% | - | |
0.01% | 773 M€ | -.--% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 4.91 | +0.82% | 985,301 |
24-04-25 | 4.87 | -3.18% | 1,540,488 |
24-04-24 | 5.03 | -1.18% | 786,047 |
24-04-23 | 5.09 | +0.79% | 920,655 |
24-04-22 | 5.05 | +1.20% | 1,167,172 |
Delayed Quote Nasdaq, April 26, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-45.38% | 704M | |
-2.31% | 103B | |
+0.56% | 95.71B | |
+1.69% | 22.02B | |
-17.37% | 20.9B | |
-9.30% | 17.85B | |
-41.01% | 16.21B | |
-14.85% | 15.52B | |
+3.21% | 13.86B | |
+33.54% | 12.04B |
- Stock Market
- Equities
- AUPH Stock